Relapsing fever refers to a group of infectious diseases caused by Borrelia species of the relapsing fever group, which are distinct from the Borrelia burgdorferi sensu lato complex responsible for Lyme borreliosis [3][2]. The causative spirochetes are transmitted to humans chiefly by soft-bodied argasid ticks, with two notable exceptions: Borrelia recurrentis, transmitted by the human body louse, and Borrelia miyamotoi, transmitted by hard-bodied ixodid ticks [2]. Relapsing fever Borrelia exhibit multiphasic antigenic variation, which underlies the characteristic relapsing clinical course [2].
Aperçu de la maladie
BactérienneRelapsing fever is a bacterial zoonosis caused by multiple Borrelia species and transmitted primarily through tick or louse vectors, with distinct louse-borne and tick-borne epidemiological profiles worldwide [1][2]. It is characterized by recurrent febrile episodes driven by antigenic variation of the spirochete, along with diverse clinical manifestations including hematologic, neurologic, and systemic complications [1][2]. Although historically associated with large epidemics, it remains a globally distributed yet under-recognized disease with active endemic foci [1].
Lire le profil clinique et épidémiologique complet 6
The hallmark clinical feature of relapsing fever is the eponymous relapsing fever pattern, characterized by recurrent episodes of high fever alternating with afebrile periods, present in essentially all cases [1]. Acute episodes typically present with abrupt onset of fever, rigors, headache, myalgia, and prostration, and may be accompanied by thrombocytopenia as the most suggestive laboratory finding [1]. Neurological complications are frequently reported, particularly in tick-borne relapsing fever, and severe manifestations can include Jarisch-Herxheimer reactions following treatment [1].
Tick-borne relapsing fever displays a patchy global distribution, with Borrelia-carrying ticks reported on all continents except Antarctica and Australia, and the epidemiogeographic pattern continues to evolve as molecular diagnostics expand knowledge of circulating species [1]. Because the disease is geographically focal, knowledge of several clinical aspects remains limited and large clinical studies are lacking [1]. The patchy occurrence and under-recognition of cases continue to constrain comprehensive epidemiologic characterization [1].
Most relapsing fever Borrelia species are transmitted to humans through the bite of soft-bodied argasid ticks, while Borrelia miyamotoi is transmitted by hard-bodied ixodid ticks [1][2]. Louse-borne relapsing fever is transmitted from human to human via the body louse Pediculus humanus corporis, through inoculation of louse coelomic fluid or feces during scratching, with possible nosocomial transmission from contaminated blood [4]. Tick vectors acquire the spirochetes during blood feeding from infected vertebrate reservoirs, maintaining the zoonotic transmission cycle [1][2].
Prevention of relapsing fever centers on reducing exposure to arthropod vectors, including avoidance of tick habitats and use of protective measures against tick bites, as well as control of body louse infestations in settings where louse-borne transmission occurs [5]. Early recognition and treatment of suspected tick-borne illness is emphasized to decrease morbidity and mortality, with published treatment guidelines available from public health authorities [5].
- 1 Jakab Á et al. Tick borne relapsing fever - a systematic review and analysis of the literature. PLoS Negl Trop Dis. 2022 Feb. PMID: 35171908. doi: 10.1371/journal.pntd.0010212. PubMed: https://pubmed.ncbi.nlm.nih.gov/35171908/
- 2 Lopez J et al. Pathogenesis of Relapsing Fever. Curr Issues Mol Biol. 2021. PMID: 33372163. doi: 10.21775/cimb.042.519. PubMed: https://pubmed.ncbi.nlm.nih.gov/33372163/
- 3 Cutler SJ et al. Diagnosing Borreliosis. Vector Borne Zoonotic Dis. 2017 Jan. PMID: 28055580. doi: 10.1089/vbz.2016.1962. PubMed: https://pubmed.ncbi.nlm.nih.gov/28055580/
- 4 Warrell DA et al. Louse-borne relapsing fever (Borrelia recurrentis infection). Epidemiol Infect. 2019 Jan. PMID: 30869050. doi: 10.1017/S0950268819000116. PubMed: https://pubmed.ncbi.nlm.nih.gov/30869050/
- 5 Choi E et al. Tick-Borne Illnesses. Curr Sports Med Rep. 2016 Mar-Apr. PMID: 26963018. doi: 10.1249/JSR.0000000000000238. PubMed: https://pubmed.ncbi.nlm.nih.gov/26963018/
- A68
- 1C21
Chargement des données actuelles…
Tendances nationales
Choisissez le pays, la source et la mesure ; chaque courbe conserve sa période et sa définition de déclaration.
Couverture des données
Pays et régions déclarants
La carte montre la couverture déclarée. Choisissez une mesure ou ouvrez un lieu coloré pour consulter ses données.
Chargement des données actuelles…
Profil de surveillance
Saisonnalité du pays sélectionné
Consultez les valeurs mensuelles d’un pays par année. Les cases vides indiquent une valeur non publiée.
Radar de recherche
Recherches récentes associées
Quantitative polymerase chain reaction from malaria rapid diagnostic tests to detect Borrelia crocidurae in Mali
PLOS Neglected Tropical Diseases
The global distribution and the risk prediction of relapsing fever group Borrelia: a data review with modelling analysis
The Lancet Microbe
Diversity and distribution of the tick-borne relapsing fever spirochete Borrelia turicatae
PLOS Neglected Tropical Diseases
A new Borrelia on the block: Borrelia miyamotoi – a human health risk?
Eurosurveillance
Louse-borne relapsing fever ( Borrelia recurrentis infection)
Epidemiology and Infection
5 publications associées sur 8 affichées.
Les liens bibliographiques servent à découvrir des travaux et ne modifient ni ne valident la série de surveillance ci-dessus.
Chargement des alertes officielles…
Téléchargement et méthodes
Choisissez une période et téléchargez les fichiers CSV, JSON ou XLSX.

